Yeagyeong Hwang

University of California, Irvine Medical Center

Papers

Total Citations

H-Index

About

Dr. Yeagyeong Hwang is a leading urologic oncologist whose research centers on optimizing surgical outcomes in prostate cancer, particularly through robotic-assisted techniques. Her most impactful work challenges long-held assumptions about positive surgical margins (PSMs) after radical prostatectomy. In a landmark international multi-institutional study, Dr. Hwang demonstrated that unifocal PSMs (UPSMs) do not significantly impact prostate cancer-specific mortality (PCSM)—a finding that has reshaped clinical risk assessment and surgical decision-making. Her 2024 paper on the interplay between surgical margin status and tumor volume in robotic radical prostatectomy, already garnering early citations, further refines prognostic models for post-surgical survival. Beyond this, Dr. Hwang’s contributions extend to advancing minimally invasive surgical standards, with her research influencing guidelines on margin evaluation and patient counseling. Her work is widely cited for its rigorous methodology and direct clinical implications, offering surgeons and patients nuanced insights into oncologic outcomes. Dr. Hwang’s dedication to evidence-based urology continues to drive improvements in prostate cancer management, making her a pivotal figure in the field.